Apidra solostar and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Apidra solostar (insulin glulisine recombinant), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Lantus Solostar, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Heart attack when taking Apidra solostar. It is created by eHealthMe based on reports of 1,930 people who have side effects when taking Apidra solostar from the FDA, and is updated regularly.

What is Apidra solostar?

Apidra solostar has active ingredients of insulin glulisine recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 1,951 Apidra solostar users. Check the latest studies of Apidra solostar.

What is Heart attack?

Heart attack is found to be associated with 2,485 drugs and 3,296 conditions by eHealthMe. Check the latest studies of Heart attack.

On Jul, 11, 2026

1,930 people reported to have side effects when taking Apidra solostar.
Among them, 21 people (1.09%) have Heart attack.

Could Apidra solostar cause Heart attack?

Among these 21 people:

How long have people been on Apidra solostar when they have Heart attack? *

What is the gender of people who have Heart attack when taking Apidra solostar? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Heart attack when taking Apidra solostar? *

What are other drugs people take besides Apidra solostar? *

What are other side effects people have besides Heart attack? *

Blood Glucose Increased: 4 people, 19.05%
Hyperglycemia (high blood sugar): 3 people, 14.29%
Neuropathy Peripheral (surface nerve damage): 2 people, 9.52%
Cardiac Failure Congestive: 2 people, 9.52%
Dyspnea (difficult or laboured breathing): 2 people, 9.52%
Hospitalisation: 2 people, 9.52%
Wound Complication: 2 people, 9.52%
Acute Kidney Failure: 2 people, 9.52%
Ulcer Haemorrhage (bleeding ulcer): 2 people, 9.52%
Type 2 Diabetes: 1 person, 4.76%

What are the existing conditions these people have? *

Type 2 Diabetes: 7 people, 33.33%
High Blood Cholesterol: 2 people, 9.52%
Cardiac Disorder: 2 people, 9.52%
Nephropathy (damage to or disease of a kidney): 2 people, 9.52%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 9.52%
Gout (uric acid crystals building up in the body): 1 person, 4.76%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.76%
Cardiac Failure: 1 person, 4.76%
Chronic Kidney Disease: 1 person, 4.76%
Depression: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Apidra solostar and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apidra solostar:

Apidra solostar (1,951 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

Browse all side effects of Apidra solostar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,485 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,296 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glulisine recombinant (the active ingredients of Apidra solostar) and Apidra solostar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.